On July 23, Albertsons Companies, Inc. declined 23.9% in regular trading, trading at $11.125/share, with turnover of $283 million.

The sharp sell-off was triggered by a combination of deeply disappointing fiscal Q1 results and a drastic full-year guidance reduction. The company reported adjusted EPS of $0.42, missing the consensus estimate of $0.54 by over 22% and declining 23.6% year-over-year. More critically, management slashed its fiscal 2026 adjusted EPS guidance to $1.75-$1.85, down approximately 20% from the prior range of $2.22-$2.32 and well below the Street estimate of $2.27.

Adding to investor concerns, CFO and President Sharon McCollam announced plans to retire later this year. Additionally, the company cited an estimated 150 basis point headwind from Medicare drug price negotiation provisions under the Inflation Reduction Act. The CEO noted consumers are increasingly shifting toward private-label products and trade-down behavior, with low-income shoppers facing mounting financial pressure. To address these challenges, Albertsons is restructuring from 11 divisions into 4 regional units.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)